HealthCare Global Enterprises Limited (NSE:HCG)
India
· Delayed Price · Currency is INR 496.95
-3.05 (-0.61%)
Mar 13, 2025, 3:30 PM IST
NSE:HCG Revenue
HealthCare Global Enterprises had revenue of 5.59B INR in the quarter ending December 31, 2024, with 18.88% growth. This brings the company's revenue in the last twelve months to 21.32B, up 14.69% year-over-year. In the fiscal year ending March 31, 2024, HealthCare Global Enterprises had annual revenue of 19.12B with 12.85% growth.
Revenue (ttm)
21.32B
Revenue Growth
+14.69%
P/S Ratio
3.25
Revenue / Employee
3.47M
Employees
6,150
Market Cap
69.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 19.12B | 2.18B | 12.85% |
| Mar 31, 2023 | 16.94B | 2.97B | 21.22% |
| Mar 31, 2022 | 13.98B | 3.84B | 37.93% |
| Mar 31, 2021 | 10.13B | -822.03M | -7.50% |
| Mar 31, 2020 | 10.96B | 1.17B | 11.95% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Zydus Lifesciences | 222.47B |
| Apollo Hospitals Enterprise | 211.46B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
HealthCare Global Enterprises News
- 6 days ago - Q3 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript - GuruFocus
- 17 days ago - KKR & Co Inc (KKR) Acquires Majority Stake in Healthcare Global Enterprises - GuruFocus
- 18 days ago - Healthcare Global stock jump 3.2% after KKR announces 54% stake acquisition for $400 million - Business Upturn
- 18 days ago - KKR to buy 51% in oncology hospital HealthCare Global - The Times of India
- 18 days ago - KKR acquires 54% stake in in Healthcare Global Enterprises for Rs 3,468 crore - Business Upturn
- 4 months ago - HealthCare Global Enterprises Ltd (NSE:HCG) Q2 FY25 Earnings Call Highlights: Robust Revenue ... - GuruFocus
- 4 months ago - Q2 2025 Healthcare Global Enterprises Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Healthcare Global Enterprises Q2 FY25 Results: Revenue at ₹552.47 Crore, Up 13.9% YoY; Profit at ₹20.68 Crore, Up 91.7% YoY - Business Upturn